| #279 |
Brian Zimmerly |
Tesla |
1 |
| #279 |
Matthew T. Burtch |
Magna International |
1 |
| #279 |
Deborah Lee Zimmerman |
Novartis Vaccines And Diagnostics |
1 |
| #279 |
Naomi S. Ginsberg |
University of California |
1 |
| #279 |
Garner Chung |
Opower |
1 |
| #279 |
Michael J. Gerber |
Abb Vie Deutschland |
1 |
| #279 |
William K. Warburton |
Unknown |
1 |
| #279 |
Leonard Katz |
Kosan Biosciences Incorporated |
1 |
| #279 |
Kiyo Kubo |
Aruba Networks |
1 |
| #279 |
Jake Kimball |
Fluidigm |
1 |
| #279 |
Gary S. Ott |
Chiron |
1 |
| #279 |
Blake Wiedenheft |
University of California |
1 |
| #279 |
Nicolas Newton |
Roche Molecular Systems |
1 |
| #279 |
Peter Lester |
Comcast |
1 |
| #279 |
Elizabeth Schulte |
Sunpower |
1 |
| #279 |
John E. Dueber |
University of California |
1 |
| #279 |
Mark Knapp |
Novartis Ag |
1 |
| #279 |
Helen M. Gould |
Ebay |
1 |
| #279 |
Megan Van Overbeek |
Caribou Biosciences |
1 |
| #279 |
William L. Heyward |
Dynavax Technologies |
1 |
| #279 |
Homer A. Boushey |
University of California |
1 |
| #279 |
Christopher Grimmer |
Banyan Energy |
1 |
| #279 |
Yves Behar |
Superflex |
1 |
| #279 |
Pragash Sangaran |
— |
1 |
| #279 |
Hang Yee Wong |
Siebel Systems |
1 |
| #279 |
Alan R. Hanson |
Emc Ip Holding Company |
1 |
| #279 |
Matthew T. Vogel |
Abbott |
1 |
| #279 |
Elizabeth Karger |
— |
1 |
| #279 |
Riley Stewart Bingham |
— |
1 |
| #279 |
Jesse Endahl |
Dropbox |
1 |
| #279 |
Alisa Clemmons |
Meta |
1 |
| #279 |
Kimberly Goodrich |
— |
1 |
| #279 |
Jason M. Gardner |
Marqeta |
1 |
| #279 |
Daniel Suyeyasu |
— |
1 |
| #279 |
Sharon Ellen Kallenberger |
Charcoal Companion Limited |
1 |
| #279 |
Campbell Kennedy |
RTX (Raytheon) |
1 |
| #279 |
Eric Scott Eisher |
Amazon |
1 |
| #279 |
Michael Bregante |
— |
1 |
| #279 |
Raymond J. Bregante |
— |
1 |
| #279 |
Safiali Rouhi |
Quantenna Communications |
1 |
| #279 |
Dmitry Demeschchuk |
Satori Worldwide |
1 |
| #279 |
Hyon Bae |
Youngbo Engineering |
1 |
| #279 |
Jeffrey Orion Pritchard |
Intel |
1 |
| #279 |
Peter Baker |
Andrew |
1 |
| #279 |
Eivind Sarto |
Espial Group |
1 |
| #279 |
Henry A. Erlich |
Roche Molecular Systems |
1 |
| #279 |
Eicke R. Weber |
University of California |
1 |
| #279 |
Lauren Barr |
— |
1 |
| #279 |
Wosenu Mergo |
Novartis Ag |
1 |
| #279 |
Karling Alice Leung |
Intarcia Therapeutics |
1 |